New Therapeutic Approaches for Conjunctival Melanoma—What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells

Conjunctival melanoma (CM) accounts for 5% of all ocular melanomas and arises from malignantly transformed melanocytes in the conjunctival epithelium. Current therapies using surgical excision in combination with chemo- or cryotherapy still have high rates for recurrences and metastatic disease. Lat...

Descripción completa

Detalles Bibliográficos
Autores principales: Peil, Jennifer, Bock, Felix, Kiefer, Friedemann, Schmidt, Rebecca, Heindl, Ludwig M., Cursiefen, Claus, Schlereth, Simona L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835854/
https://www.ncbi.nlm.nih.gov/pubmed/35163401
http://dx.doi.org/10.3390/ijms23031478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835854/
https://www.ncbi.nlm.nih.gov/pubmed/35163401
http://dx.doi.org/10.3390/ijms23031478

Ejemplares similares